Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5274-5281

  Van Marle, Guido ^a   Van Dinten, Leonie C ^a   Spaan, Willy J M ^a   Luytjes, Willem ^a   Snijder, Eric J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MUTANT PROTEIN; PROLINE; RNA DIRECTED RNA POLYMERASE; SERINE; VIRUS MESSENGER RNA; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; EQUINE VIRAL ARTERITIS VIRUS; MESSENGER RNA SYNTHESIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA ANALYSIS; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; VIRUS MUTANT;

EID: 0033031789     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5274-5281.1999     Document Type: Article

References (55)

1. An, S., and S. Makino. 1998. Characterizations of coronavirus cis-acting RNA elements and the transcription step affecting its transcription efficiency. Virology 243:198-207.
2. Andino, R., G. E. Rieckhof, P. L. Achacoso, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:3587-3598.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
4. Baker, S. C., and M. M. C. Lai. 1990. An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J. 9:4173-4179.
5. Baric, R. S., S. A. Stohlman, and M. M. C. Lai. 1983. Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J. Virol. 48:633-640.
6. Blair, W. S., X. Li, and B. L. Semler. 1993. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor. J. Virol. 67:2336-2343.
7. Brian, D. A., and W. J. M. Spaan. 1997. Recombination and coronavirus defective interfering RNAs. Semin. Virol. 8:101-111.
8. Cao, X., and E. Wimmer. 1996. Genetic variation of the poliovirus genome with two VPg coding units. EMBO J. 15:23-33.
9. Cavanagh, D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 142:629-633.
10. Chang, R. Y., M. A. Hofmann, P. B. Sethna, and D. A. Brian. 1994. A cis-acting function for the coronavirus leader in defective interfering RNA replication. J. Virol. 68:8223-8231.
11. Chang, R. Y., R. Krishnan, and D. A. Brian. 1996. The UCUAAAC promoter motif is not required for high-frequency leader recombination in bovine coronavirus defective interfering RNA. J. Virol. 70:2720-2729.
12. Chen, Z., L. Kuo, R. R. R. Rowland, C. Even, K. S. Faaberg, and P. G. W. Plagemann. 1993. Sequences of 3′ end of genome and of 5′ end of open reading frame 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5′ leader and bodies of seven subgenomic mRNAs. J. Gen. Virol. 74:643-659.
13. den Boon, J. A., W. J. M. Spaan, and E. J. Snijder. 1995. Equine arteritis virus subgenomic RNA transcription: UV inactivation and translation inhibition studies. Virology 213:364-372.
14. den Boon, J. A., M. F. Kleijnen, W. J. M. Spaan, and E. J. Snijder. 1996. Equine arteritis virus subgenomic mRNA synthesis: analysis of leader-body junctions and replicative-form RNAs. J. Virol. 70:4291-4298.
15. den Boon, J. A., E. J. Snijder, E. D. Chirnside, A. A. F. de Vries, M. C. Horzinek, and W. J. M. Spaan. 1991. Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J. Virol. 65:2910-2920.
16. de Vries, A. A. F., E. D. Chirnside, P. J. Bredenbeek, L. A. Gravestein, M. C. Horzinek, and W. J. M. Spaan. 1990. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucleic Acids Res. 18: 3241-3247.
17. de Vries, A. A. F., E. D. Chirnside, M. C. Horzinek, and P. J. M. Rottier. 1992. Structural proteins of equine arteritis virus. J. Virol. 66:6294-6303.
18. de Vries, A. A. F., M. C. Horzinek, P. J. M. Rottier, and R. J. de Groot. 1997. The genome organization of the Nidovirales: similarities and differences between arteri-, toro-, and coronaviruses. Semin. Virol. 8:33-47.
19. Doll, E. R., J. T. Bryans, W. H. McCollum, and M. E. W. Crowe. 1957. Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus. Cornell Vet. 47:3-41.
20. Godeny, E. K., A. A. F. de Vries, X. C. Wang, S. L. Smith, and R. J. de Groot. 1998. Identification of the leader-body junctions for the viral subgenomic mRNAs and organization of the simian hemorrhagic fever virus genome: evidence for gene duplication during arterivirus evolution. J. Virol. 72:862-867.
21. Gorbalenya, A. E., E. V. Koonin, A. P. Donchenko, and V. M. Blinov. 1989. Coronavirus genome: prediction of putative functional domains in the non-structural polyprotein by comparative amino acid sequence analysis. Nucleic Acids Res. 17:4847-4861.
22. Harris, K. S., S. R. Reddigari, M. J. Nicklin, T. Hammerle, and E. Wimmer. 1992. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J. Virol. 66:7481-7489.
23. Hiscox, J. A., K. L. Mawditt, D. Cavanagh, and P. Britton. 1995. Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J. Virol. 69:6219-6227.
24. Jacobs, L., W. J. M. Spaan, M. C. Horzinek, and B. A. M. van der Zeijst. 1981. Synthesis of subgenomic mRNAs of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping. J. Virol. 39:401-406.
25. Jeong, Y. S., J. F. Repass, Y. N. Kim, S. M. Hwang, and S. Makino. 1996. Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology 217:311-322.
26. Kadare, G., and A. L. Haenni. 1997. Virus-encoded RNA helicases. J. Virol. 71:2583-2590.
27. Lai, M. M. C., R. S. Baric, P. R. Brayton, and S. A. Stohlman. 1984. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA 81:3626-3630.
28. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
29. Lai, M. M. C., C. D. Patton, and S. A. Stohlman. 1982. Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J. Virol. 44:487-492.
30. Lemm, J. A., T. Rumenapf, E. G. Strauss, J. H. Strauss, and C. M. Rice. 1994. Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus-and plus-strand RNA synthesis. EMBO J. 13:2925-2934.
31. Makino, S., and M. Joo. 1993. Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J. Virol. 67:3304-3311.
32. Makino, S., M. Joo, and J. K. Makino. 1991. A system for study of coronavirus messenger RNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65:6031-6041.
33. Meulenberg, J. J. M., E. J. de Meijer, and R. J. M. Moormann. 1993. Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction sequence. J. Gen. Virol. 74:1697-1701.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, N.Y.
35. Sawicki, S. G., and D. L. Sawicki. 1990. Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 64:1050-1056.
36. Sawicki, S. G., and D. L. Sawicki. 1995. Coronaviruses use discontinuous extension for synthesis of subgenome-length negative strands. Adv. Exp Biol. Med. 380:499-506.
37. Sawicki, S. G., and D. L. Sawicki. 1998. A new model for coronavirus transcription, p. 215-219. In L. Enjuanes, S. G. Siddell, and W. J. M. Spaan (ed.), Coronaviruses and arteriviruses, Plenum Press, New York, N.Y.
38. Schaad, M. C., and R. S. Baric. 1994. Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J. Virol. 68:8169-8179.
39. Sethna, P. B., and D. A. Brian. 1997. Coronavirus genomic and subgenomic minus-strand RNAs copartition in membrane-protected replication complexes. J. Virol. 71:7744-7749.
40. Sethna, P. B., M. A. Hofmann, and D. A. Brian. 1991. Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J. Virol. 65:320-325.
41. Sethna, P. B., S. L. Hung, and D. A. Brian. 1989. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. Natl. Acad. Sci. USA 86:5626-5630.
42. Shirako, Y., and J. H. Strauss. 1994. Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J. Virol. 68:1874-1885.
43. Snijder, E. J., and J. J. M. Meulenberg. 1998. The molecular biology of arteriviruses. J. Gen. Virol. 79:961-979.
44. Snijder, E. J., A. L. M. Wassenaar, and W. J. M. Spaan. 1994. Proteolytic processing of the replicase ORF1a protein of equine arteritis virus. J. Virol. 68:5755-5764.
45. Spaan, W. J. M., H. Delius, M. Skinner, J. Armstrong, P. J. M. Rottier, S. Smeekens, B. A. M. van der Zeijst, and S. G. Siddell. 1983. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J. 2:1839-1844.
46. van Berlo, M. F., M. C. Horzinek, and B. A. M. van der Zeijst. 1982. Equine arteritis virus-infected cells contain six polyadenylated virus-specific RNAs. Virology 118:345-352.
47. van der Most, R. G., R. J. de Groot, and W. J. M. Spaan. 1994. Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J. Virol. 68: 3656-3666.
48. van der Most, R. G., and W. J. M. Spaan. 1995. Coronavirus replication, transcription, and RNA recombination, p. 11-31. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
49. van Dinten, L. C., J. A. den Boon, A. L. M. Wassenaar, W. J. M. Spaan, and E. J. Snijder. 1997. An infectious arterivirus cDNA clone: identification of a replicase point mutation which abolishes discontinuous mRNA transcription. Proc. Natl. Acad. Sci. USA 94:991-996.
50. van Dinten, L. C., S. Rensen, W. J. M. Spaan, A. E. Gorbalenya, and E. J. Snijder. 1999. Proteolytic processing of the ORF1b-encoded part of the arterivirus replicase is mediated by the nsp4 serine protease and is essential for virus replication. J. Virol. 73:2027-2037.
51. van Dinten, L. C., A. L. M. Wassenaar, A. E. Gorbalenya, W. J. M. Spaan, and E. J. Snijder. 1996. Processing of the equine arteritis virus replicase ORF1b protein: identification of cleavage products containing the putative viral polymerase and helicase domains. J. Virol. 70:6625-6633.
52. van Marle, G., J. C. Dobbe, A. P. Gultyaev, W. Luytjes, W. J. M. Spaan, and E. J. Snijder. Unpublished data.
53. van Marle, G., W. Luytjes, R. G. van der Most, T. van der Straaten, and W. J. M. Spaan. 1995. Regulation of coronavirus mRNA transcription. J. Virol. 69:7851-7856.
54. Wassenaar, A. L. M., W. J. M. Spaan, A. E. Gorbalenya, and E. J. Snijder. 1997. Alternative proteolytic processing of the arterivirus ORF1a polyprotein: evidence that nsp2 acts as a cofactor for the nsp4 serine protease. J. Virol. 71:9313-9322.
55. Yokomori, K., L. R. Banner, and M. M. C. Lai. 1992. Coronavirus mRNA transcription: UV light transcriptional mapping studies suggest an early requirement for a genomic-length template. J. Virol. 66:4671-4678.